Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

• Published in: PloS one 2009-05, Vol.4 (5), p.e5424-e5424
• Main Authors: Li, Ge, Peskind, Elaine R, Millard, Steven P, Chi, Peter, Sokal, Izabela, Yu, Chang-En, Bekris, Lynn M, Raskind, Murray A, Galasko, Douglas R, Montine, Thomas J
• Format: Article
• Language: English
• Subjects: Adult; Adults; Advertising executives; Age; Aged; Aged, 80 and over; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - genetics; Alzheimer Disease - psychology; Alzheimer's disease; Alzheimers disease; Amyloid beta-Peptides - cerebrospinal fluid; Animal cognition; Apolipoprotein E; Apolipoproteins; Apolipoproteins E - genetics; Behavioral sciences; Brain; Brain research; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - cerebrospinal fluid; Brain-Derived Neurotrophic Factor - genetics; Case-Control Studies; Cerebrospinal fluid; Cognition - physiology; Cognition Disorders - cerebrospinal fluid; Cognition Disorders - genetics; Cognition Disorders - psychology; Cognitive ability; Cross-Sectional Studies; Cytokines; Dementia; Demographics; Education; Female; Genotype; Genotypes; Geriatrics/Dementia; Humans; Hypotheses; Longitudinal Studies; Male; Medicine; Memory; Memory - physiology; Mental disorders; Mental Health/Alzheimer Disease; Middle Aged; Neural networks; Neurodegenerative diseases; Neurological Disorders/Alzheimer Disease; Neuropsychological Tests; Older people; Parkinson's disease; Parkinsons disease; Patients; Peptide Fragments - cerebrospinal fluid; Proteomics; Psychiatry; Studies; Synaptic plasticity; Tau protein; Variance analysis; Veterans; Vitamin E; Young Adult
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0005424

Brain-derived neurotrophic factor (BDNF) is an activity-dependent secreted protein that is critical to organization of neuronal networks and synaptic plasticity, especially in the hippocampus. We tested hypothesis that reduced CSF BDNF is associated with age-related cognitive decline. CSF concentration of BDNF, Abeta(42) and total tau were measured in 128 cognitively normal adults (Normals), 21 patients with Alzheimer's disease (AD), and nine patients with Mild Cognitive Impairment. Apolipoprotein E and BDNF SNP rs6265 genotype were determined. Neuropsychological tests were performed at baseline for all subjects and at follow-up visits in 50 Normals. CSF BDNF level was lower in AD patients compared to age-matched Normals (p = 0.02). CSF BDNF concentration decreased with age among Normals and was higher in women than men (both p